RE: AstraZeneca - Guardant Health - Angle Plc - Love triangle03 May 2021 20:04
You may have hit the nail on the head Diversified. The use of the term 'household name' would be a little unusual when talking about pharma as even the best known pharma's are hardly household names...at least that WAS the case until the Covid vaccine came along and AstraZeneca became a name familiar to virtually every household in the UK.
As long as they aren't aware of impending events that will move the SP then M.Diggle / Vulpes are free to buy and sell shares whenever they want. Being a non-exec does not necessarily mean that M.Diggle has day to day operational knowledge of when events happen, and if he does not then the fact that Vulpes bought shares last week does not mean that news is not imminent. It may well be that M.Diggle has specifically asked not to be kept in the loop with day to day events in order to avoid a situation where Vulpes cannot trade die to his inside knowledge (there is no reason why a non-exec should be kept aware of day to day progress and events as non-execs aren't involved in the day to day running of the co.).
Th kind of Pharma that would buy AGL would be one that has a significant focus on diagnostics such as Abbott or Thermo Fisher. Given then the potential profit that Parsortix could generate for them they will be keen to acquire AGL IMO.